AKT1 MODULATORS

Claims

This description provides AKT1 inhibitors, pharmaceutical compositions comprising the inhibitor compounds, and methods for using the AKT1 inhibitor compounds for the treatment of diseases. A compound having the structure of formula (1), or a pharmaceutically acceptable salt, solvate, or deuteroisotope thereof. A pharmaceutical composition comprising a compound, or a pharmaceutically acceptable salt, solvate, or deuteroisotope thereof, as described in any one of claims 1-75, and a pharmaceutically acceptable excipient. A method for preparing a pharmaceutical composition comprising mixing a compound, or a pharmaceutically acceptable salt, solvate, or deuteroisotope thereof, of any one of claims 1-75, and a pharmaceutically acceptable carrier.